MAP2K7 and hepatocellular carcinoma: Raf/MEK/ERK, PI3K/Akt/mTOR and Jak/STAT pathways are downstream cell signaling of RTKs in HCC to drive cell survival, proliferation, migration, angiogenesis and metastasis [5].